Drug
HS 10383
HS 10383: highest development phase Phase 2, developed by Hansoh Pharmaceutical. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Hansoh Pharmaceutical
Trials
| Drug | Phase | Indication |
|---|---|---|
| HS-10383 NCT06246565 | Phase 2 | Cough |
| HS-10383 NCT05429723 | Phase 1 | Cough |
Latest
No recent events.
Follow HS 10383 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.